ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "In Re: - Life Sciences Series: Regulatory risks in China"
Episode Synopsis
Martina Rozumberkova for a discussion with Principal Regina Zhou about the evolving regulatory environment and the challenges of operating in China. They explore key lessons from high-profile investigations, the strategic importance of robust compliance frameworks, and recent regulatory reforms, like data transfer regulations and foreign investment in medical innovations — as well as new opportunities, despite the complexities of the landscape.
Find out more.
Find out more.
More episodes of the podcast Control Risks
In Re: - Enemies of M&A: fraud risk
31/07/2025
In God we trust